摘要 |
Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (I): wherein: R<SUB>4 </SUB>is hydrogen, and R<SUB>1</SUB>, R<SUB>2 </SUB>and R<SUB>3 </SUB>together provide a specific substitution pattern, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, are useful in the treatment of hepatitis C.
|